Optum

Organization

Optum's three businesses, OptumRx, OptumHealth and OptumInsight focus on five core capabilities: data and analytics, pharmacy care services, population health, healthcare delivery and healthcare operations.[4] Optum serves employers, government agencies, health plans, life science companies, care providers and individuals and families offering products in data and analytics, pharmacy care services, health care operations and delivery, population health management and advisory services.[8] The Optum Serve division provides health-related services to U.S. government agencies.[9] In January 2013 Optum, in partnership with Mayo Clinic, unveiled Optum Labs, a health data initiative.[10] In October 2013 Optum, in partnership with Dignity Health, launched Optum 360, a revenue cycle management venture.[11]

Major acquisitions

Since Optum's founding in 2011, the company has acquired various healthcare technology services to build out its pharmacy benefit manager and care services offerings.

February 2014: Optum purchases a majority stake in Audax Health Solutions, a digital health company working to incentivize better consumer health behaviors. Audax is later rebranded as Rally Health.[12] April 2015: Optum acquires MedExpress, an urgent care and preventative services company.[13] July 2015: Catamaran, a pharmacy benefit manager, joins OptumRx.[4] January 2017: Optum acquires Surgical Care Affiliates, an ambulatory surgery center and surgical hospital provider.[14] August 2017: Optum announces it will acquire Advisory Board Company's healthcare business.[4] December 2017: Optum announces acquisition of DaVita Medical Group from DaVita Inc.[15] April 2018: Optum acquires Reliant Medical Group, the largest independent group medical practice in Massachusetts.[16] September 2018: OptumRx announces acquisition of Genoa Healthcare, a pharmacy specializing in chronic disease management.[17] September 2019: UnitedHealth Group announces acquisition of Equian, LLC for $3.2 billion.[18] A Payment Integrity Institution that has joined the Optum family. October 2019: Optum acquired hCentive, Inc., a Reston, Virginia–based developer of software for health insurance marketplaces (terms undisclosed).[19][20][21][22] January 2021: UnitedHealth Group announces acquisition of Change Healthcare LLC, evaluated to worth $8 billion, in addition to paying off its $5 billion debt for a total of $13 billion.[23] It is said to be merged with OptumInsight. August 2021: UnitedHealth Group announces acquisition of Solutran LLC.[24] May 2022: Optum acquires Atrius Health, an independent physician-led healthcare organization.[25] June 2022: Bordeaux UK Holdings II Limited, an affiliate of Optum business acquires EMIS Health for a 49% premium on its closing share price.[26] July 2022: Optum acquires Caremount Medical, Inc., of southeastern New York State, Riverside Medical Care of New Jersey, and ProHealth Medical Group of Western Connecticut, three midsized physician-led independent medical groups. In its announcement to the public and patients of the acquisitions, insurance company UnitedHealth Group is not mentioned, casting the transaction as a merger of three midsize physician-led companies into a new company rather than three acquisitions by an existing much larger Fortune 500 corporation with multiple types of health-related acquisitions, as described above.[27] June 2023: Optum agreed to acquire Amedisys for $3.3 billion. As part of the agreement, Amedisys rejected a prior buyout offer from Option Care that it initially agreed to the previous month.[28][29] August 2025: Optum acquires Holston Medical Group, a physician-owned healthcare organization with 200+ providers and 70+ locations primarily serving Northeast Tennessee and Southwest Virginia.[30] This Optum-UnitedHealth model of vertical integration[31] is pointed to as having sparked a pattern of acquisition activity in the healthcare industry; most notably, mega-mergers between CVS-Aetna, Cigna-Express Scripts and Humana-Kindred.[32] "Optum's been the leader in showing how a managed care organization with an ambulatory care delivery platform and a pharmacy benefit manager all in house can lower or maintain and bend cost trend and then drive better market share gains in their health insurance business. I think they have been the impetus in the large space for the Aetna-CVS deal," Ana Gupte, managing director of healthcare services at Leerink, said in an interview with Healthcare Dive.[4] "Vertical integration" has met with considerable pushback and claims of antitrust law violations. The Federal Trade Commission (FTC) has accused major pharmacy benefit managers (PBMs), including CVS Caremark and OptumRx, of engaging in anticompetitive practices that harm competition and raise drug prices, citing conflicts of interest and exclusivity provisions.[33][34] Similarly, the American Medical Association (AMA) has criticized the CVS-Aetna merger, arguing it undermines competition in pharmacy benefit management services, health insurance, and retail pharmacy markets, leading to higher consumer costs and fewer choices.[35]

Leadership

July 2011: Larry Renfro is named as Optum CEO.[36] March 2018: Optum announces Larry Renfro to step down as Optum CEO.[37] July 2018: Sir Andrew Witty starts as CEO of Optum.[37] February 2021: Andrew Witty appointed as CEO of UnitedHealth Group (Optum's parent company). No successor to the Optum CEO role is named.[38] April 2024: Heather Cianfrocco is named CEO of Optum.[39] April 2025: Patrick Conway is named CEO of Optum, replacing Heather Cianfrocco who has moved to a new role as executive vice president of governance, compliance, and information security at Optum.[40]

Haven lawsuit

In early 2019, UnitedHealth Group filed a lawsuit asking a U.S. district judge to stop former Optum executive, David William Smith, from working at Haven (the Amazon, JP Morgan and Berkshire-Hathaway joint-healthcare venture).[41] Optum argued that Haven is in direct competition with its business and as such, Smith's employment would be in violation of a noncompete agreement that he signed while with Optum.[42] Smith, meanwhile, asked the judge to send the parties into closed-door arbitration. Wolf rejected Optum's request and allowed Smith's, putting court proceedings on hold until the arbitration process is complete.[43]

The case garnered media attention as setting a precedent in trade secret litigation ahead of an anticipated wave of vertical integration in the healthcare industry[44] and for uncovering previously unknown details about Haven. The case has also been referred to as having shed light on the threat that pharmacy benefit managers feel to bottom lines amid mounting bipartisan pressure to control rising healthcare costs. Testimony brought by Haven chief operating officer Jack Stoddard was unsealed after a motion brought by the parent companies of Stat News and The Wall Street Journal.[45]

Worker outsourcing and layoffs

Optum and its parent company, UnitedHealth Group, have faced recurring employee complaints about excessive layoffs of U.S. staff, often linked to cost-cutting measures that include outsourcing and offshoring roles to lower-cost locations such as India and the Philippines. Anonymous reviews on sites like Glassdoor and Indeed frequently describe patterns of "rampant layoffs," "frequent restructuring and workforce reductions," "layoff seasons," and a "toxic" or "hostile" work environment with low job security. Employees report that U.S. positions are eliminated and replaced with offshore workers, contributing to perceptions of prioritizing short-term profits over workforce stability and transparency.[46][47] Specific layoffs have been documented through Worker Adjustment and Retraining Notification (WARN) Act filings, including plans to lay off 572 employees in New Jersey in early 2026 (affecting Optum Care, Optum Medical Care, and related units, with some closures of behavioral health, pediatrics, and specialty care services), and prior rounds such as over 500 positions in California in 2024.[48][49] Former employees have also alleged in online forums that large-scale reductions (sometimes framed as voluntary resignations to avoid mandatory cuts) involve replacing U.S. staff with offshore hires, though Optum has not issued detailed public responses to these specific claims beyond general statements on restructuring for market needs.

Alleged racial bias

A 2019 study published in Science, alleges the "algorithm used to manage the healthcare of millions of Americans shows dramatic biases against black patients". Said algorithm, applied to over 200 million individuals yearly, "significantly underestimates the amount of care black patients need compared with white patients". In fact, "less money is spent on black patients with the same level of need as white patients, causing the algorithm to conclude that black patients were less sick". Optum claims "its system helps 'clinicians provide more effective patient care every day.[50][51]